The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease
Oral bisphosphonates (oBP) are contraindicated in patients with severe chronic kidney disease (CKD), but there is a lack of data on safety in this area. We aimed to study the association between oBP use and risk of acute kidney injury (AKI), gastrointestinal events (GIE) and hypocalcaemia (HC) in pa...
Huvudupphovsmän: | Robinson, D, Ali, M, Pallares, N, Tebe, C, Cooper, C, Abrahamsen, B, Caskey, F, Ben-Shlomo, Y, Judge, A, Javaid, M, Diez-Perez, A, Prieto-Alhambra, D |
---|---|
Materialtyp: | Conference item |
Publicerad: |
Springer London
2018
|
Liknande verk
Liknande verk
-
The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease
av: Ali, M, et al.
Publicerad: (2018) -
Oral bisphosphonate use and risk of acute kidney injury, gastrointestinal events and hypocalcaemia in patients with moderate-advanced chronic kidney disease: a population-based cohort study
av: Ali, MS, et al.
Publicerad: (2017) -
Oral bisphosphonates and chronic kidney disease: progression and safety
av: Prieto-Alhambra, D, et al.
Publicerad: (2018) -
Oral bisphosphonate use and all‐cause mortality in patients with advanced (stage IIIB+) chronic kidney disease: a propensity score analysis
av: Alarkawi, D, et al.
Publicerad: (2018) -
Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a binational cohort analysis
av: Robinson, DE, et al.
Publicerad: (2021)